Loading news...
Shares of The Beauty Health Company (NASDAQ: SKIN - Get Free Report) have been assigned a consensus rating of "Reduce" from the seven research firms that are covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation and one has given a
NEW YORK and NEW ORLEANS, Jan. 20, 2026 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq.
Beauty Health (NASDAQ: SKIN - Get Free Report) and Pacific Health Care Organization (OTCMKTS:PFHO - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership and earnings. Profitability This table compares Beauty
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK , Dec. 5, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of The Beauty Health Company (NASDAQ: SKIN) breached their fiduciary duties to shareholders.
LONG BEACH, Calif. , Dec. 04, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today released Volume Three of its Skintuition Report, an annual deep dive into the forces shaping modern skin health. This year's report uncovers the most significant consumer-driven shifts of 2025, identifies the trends poised to define aesthetics in 2026, and offers new insight into how people are approaching longer-term skin health and regeneration.
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK , Nov. 30, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of The Beauty Health Company (NASDAQ: SKIN) breached their fiduciary duties to shareholders.
Beauty Health (NASDAQ: SKIN - Get Free Report) and COMPASS Pathways (NASDAQ: CMPS - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, valuation, earnings, profitability and risk. Analyst Recommendations This is a summary of
/PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick and Foti, LLC ("KSF"), announces that
Explore how Beauty Health's (SKIN) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
The Beauty Health Company (NASDAQ: SKIN - Get Free Report) has been given an average rating of "Hold" by the seven research firms that are presently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, one has assigned a buy rating and
The Beauty Health Company ( SKIN ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Pedro Malha - CEO & President Michael Monahan - Chief Financial Officer Conference Call Participants Norberto Aja - JCIR Oliver Chen - TD Cowen, Research Division John-Paul Wollam - ROTH Capital Partners, LLC, Research Division Susan Anderson - Canaccord Genuity Corp., Research Division Lillian Moffett - Raymond James & Associates, Inc., Research Division K. Gong - JPMorgan Chase & Co, Research Division Joseph Federico - Stifel, Nicolaus & Company, Incorporated, Research Division Presentation Operator Good day, and welcome to The Beauty Health Company 2025 Third Quarter Earnings Conference Call.
Although the revenue and EPS for Beauty Health (SKIN) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
The Beauty Health Company (SKIN) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to a loss of $0.15 per share a year ago.
LONG BEACH, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- The BeautyHealth Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced the appointment of global aesthetics leader, Philippe Schaison, PharmaD, to its Board of Directors, effective as of October 30, 2025.
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of The Beauty Health Company (NASDAQ: SKIN) breached their fiduciary duties to shareholders. If you currently own Beauty Health stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to the company, a court-approved financial incentive award, or other relief and benefits. Please click here to learn more a.
The Beauty Health Company will report third quarter 2025 financial results on November 6, and host conference call and webcast at 4:30 p.m. ET that day.
Global Healthcare and Medical Device Executive with More Than 20 Years of Experience Assumes Role Effective October 1 Marla Beck Steps Down, With BeautyHealth Prepared for Its Next Phase of Growth LONG BEACH, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced the appointment of Pedro Malha as President and Chief Executive Officer, effective October 1, 2025.
This accolade builds on a year of major awards, reinforcing Hydrafacial's proven results and trusted position with consumers and providers worldwide This accolade builds on a year of major awards, reinforcing Hydrafacial's proven results and trusted position with consumers and providers worldwide